{{flagHref}}
Products
  • Products
  • Categories
  • Blog
  • Podcast
  • Application
  • Document
|
|
/ {{languageFlag}}
Select language
Stanford Advanced Materials {{item.label}}
Stanford Advanced Materials
Select language
Stanford Advanced Materials {{item.label}}
Please start talking
a

A Red‐Light‐Activated Ruthenium‐Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells

Title A Red‐Light‐Activated Ruthenium‐Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells
Authors Lucien N. Lameijer, Daniël Ernst, Dr. Samantha L. Hopkins, Michael S. Meijer, Dr. Sven H. C. Askes, Dr. Sylvia E. Le Dévédec, Dr. Sylvestre Bonnet
Magazine Angewandte Chemie (International Ed. in English)
Date 08/09/2017
DOI 10.1002/anie.201703890
Introduction In this study, we present two water-soluble ruthenium complexes, [1]Cl2 and [2]Cl2, which release a cytotoxic nicotinamide phosphoribosyltransferase (NAMPT) inhibitor under low-dose red light, independent of oxygen. Upon red-light activation, the inhibition potency of [2]Cl2 significantly increased by up to 18-fold, while [1]Cl2 was found to be thermally unstable. The cytotoxicity of these photocaged compounds was evaluated under hypoxia (1% O2), revealing a 3- to 4-fold increase in cytotoxicity in skin (A431) and lung (A549) cancer cells upon red-light irradiation, regardless of oxygen levels (1% or 21% O2). These findings highlight the potential for photoactivated chemotherapy in treating hypoxic cancer cells, where traditional photodynamic therapy is less effective due to its reliance on oxygen activation.
Quote Lucien N. Lameijer, Daniël Ernst and Samantha L. Hopkins et al. A Red‐Light‐Activated Ruthenium‐Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells. Angew. Chem. Int. Ed. Engl. 2017. Vol. 56(38):11549-11553. DOI: 10.1002/anie.201703890
Element Ruthenium (Ru) , Oxygen (O)
Materials Chemical Compounds
Industry Pharmaceutical Industry
Related papers
Loading... Please wait...
Publish your research and articles on the SAM website
Disclaimer
This site only provides metadata for academic works to enable users to easily find relevant information. For full access to the works, please use the DOI to visit the original publisher's website. The data comes from publicly accessible scientific databases and complies with the terms of use of these platforms. If you have any concerns regarding copyright, please contact us. We will address them immediately.

Success! You are now subscribed.

You have successfully subscribed! Check your inbox soon to receive great emails from this sender.
Leave A Message
Leave A Message
* Your Name:
* Your Email:
* Product Name:
* Your Phone:
* Comments: